May 14 |
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
|
May 8 |
2 Incredible Growth Stocks to Buy Hand Over Fist
|
May 8 |
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
|
May 7 |
Kura Oncology: Balancing Act Of Promise And Pragmatism
|
May 6 |
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
|
May 4 |
Kura Oncology, Inc. (KURA) Q1 2024 Earnings Call Transcript
|
May 3 |
Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...
|
May 2 |
Kura Oncology GAAP EPS of -$0.59 misses by $0.03
|
May 2 |
Kura Oncology Reports First Quarter 2024 Financial Results
|
May 1 |
Kura Oncology Q1 2024 Earnings Preview
|